Injecting a cure

Published: Monday 31 December 2001

With the help of a chemical, diabetes sufferers with early symptoms could be prevented from developing the disease completely, research has suggested. Trials found that a specific peptide -- a substance formed from amino acids -- halted the progression of Type1 diabetes (the insulin-dependent form that must be treated with injections) in humans and mice. Jerusalem-based Hadassah-Hebrew University Medical School and Peptor Limited, a pharmaceutical company also based in Israel, conducted the research. It is hoped that the discovery could lead to the development of new life-saving drugs (, November 30, 2001).

Subscribe to Weekly Newsletter :

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.